Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06433999
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-05-23
Brief Title:
A 12-Week Open-Label Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Skin-Predominant Dermatomyositis
Sponsor:
Priovant Therapeutics Inc
Organization:
Priovant Therapeutics Inc
Organization Data
Organization:
Priovant Therapeutics Inc
Class:
INDUSTRY
Study ID:
PVT-2201-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Priovant Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None